Drug Type Small molecule drug |
Synonyms VTI 1002, VTI1002 |
Target |
Action modulators, inhibitors |
Mechanism GRB modulators(granzyme B modulators), B cells inhibitors |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Preclinical | United States | 30 Jan 2022 | |
| Inflammation | Preclinical | United States | 30 Jan 2022 | |
| Blister | Preclinical | Canada | - | |
| Pemphigoid, Bullous | Preclinical | Canada | - |





